GENEVA, Oct. 30 -- JANSSEN PHARMACEUTICA NV filed a patent application (US2026/024615) for “FCRN INHIBITOR COMPOUNDS”. With publication no. WO/2026/226608, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/404
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....